Monika Stradczuk, Łukasz Mazurek, Barbara Rękas, Wojciech Mazurek, Mateusz Piętak, Barbara Kruczyk, Wojciech Kopacz, Joanna Olędzka, Zuzanna Czach, Dominika Bachurska
{"title":"如何治疗雄激素性脱发--最常见的脱发形式。回顾","authors":"Monika Stradczuk, Łukasz Mazurek, Barbara Rękas, Wojciech Mazurek, Mateusz Piętak, Barbara Kruczyk, Wojciech Kopacz, Joanna Olędzka, Zuzanna Czach, Dominika Bachurska","doi":"10.12775/jehs.2024.73.51729","DOIUrl":null,"url":null,"abstract":"Introduction and purposeAndrogenetic alopecia (AGA) is one of the most common causes of baldness worldwide. It affects up to 80% of men by the age of 70 and up to 40% of postmenopausal women. In AGA etiology and pathogenesis, the three essential components play a key role - genetic inheritance, patient age and hormonal effects of androgens. In the following review, we have described the available FDA-approved and off-label treatments for AGA, along with their efficacy and potential side effects that should always be considered to prevent treatment discontinuation by the patients.The state of knowledgeThe pathogenesis of AGA is based on inherited dihydrotestosterone (DHT) sensitivity in the scalp skin, which leads to progressive hair loss. The literature documents the effectiveness of several treatments with different mechanisms of action in AGA therapy, but only topical minoxidil and oral finasteride gained FDA approval so far. Minoxidil acts by the blood vessels dilatation that increases the flow of oxygenated and growth factor-enriched blood to the hair follicles in the skin. 5-alpha reductase inhibitors, such as finasteride and dutasteride are another threapeutic option. Thy act by the inhibition of 5-alpha reductase, the enzyme which converts testosterone to DHT - the main causative agent of androgenetic alopecia. Recently, topical applications of minoxidil and finasterid, along with completely new emerging treatments for androgenetic alopecia are gaining popularity among doctors and patients. SummaryThis review describes current treatments for AGA, considering their efficacy, optimal doses, and the most common side effects. An important fact to emphasise is that androgenetic alopecia is based on a genetic predisposition, and treatment requires long-term use. For this reason, when choosing a medication, it is essential to cooperate with the patient and combine different therapeutic methods to achieve the desirable outcome while avoiding adverse reactions.","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"23 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How to treat androgenetic alopecia – the most common form of hair loss. A review\",\"authors\":\"Monika Stradczuk, Łukasz Mazurek, Barbara Rękas, Wojciech Mazurek, Mateusz Piętak, Barbara Kruczyk, Wojciech Kopacz, Joanna Olędzka, Zuzanna Czach, Dominika Bachurska\",\"doi\":\"10.12775/jehs.2024.73.51729\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction and purposeAndrogenetic alopecia (AGA) is one of the most common causes of baldness worldwide. It affects up to 80% of men by the age of 70 and up to 40% of postmenopausal women. In AGA etiology and pathogenesis, the three essential components play a key role - genetic inheritance, patient age and hormonal effects of androgens. In the following review, we have described the available FDA-approved and off-label treatments for AGA, along with their efficacy and potential side effects that should always be considered to prevent treatment discontinuation by the patients.The state of knowledgeThe pathogenesis of AGA is based on inherited dihydrotestosterone (DHT) sensitivity in the scalp skin, which leads to progressive hair loss. The literature documents the effectiveness of several treatments with different mechanisms of action in AGA therapy, but only topical minoxidil and oral finasteride gained FDA approval so far. Minoxidil acts by the blood vessels dilatation that increases the flow of oxygenated and growth factor-enriched blood to the hair follicles in the skin. 5-alpha reductase inhibitors, such as finasteride and dutasteride are another threapeutic option. Thy act by the inhibition of 5-alpha reductase, the enzyme which converts testosterone to DHT - the main causative agent of androgenetic alopecia. Recently, topical applications of minoxidil and finasterid, along with completely new emerging treatments for androgenetic alopecia are gaining popularity among doctors and patients. SummaryThis review describes current treatments for AGA, considering their efficacy, optimal doses, and the most common side effects. An important fact to emphasise is that androgenetic alopecia is based on a genetic predisposition, and treatment requires long-term use. For this reason, when choosing a medication, it is essential to cooperate with the patient and combine different therapeutic methods to achieve the desirable outcome while avoiding adverse reactions.\",\"PeriodicalId\":15567,\"journal\":{\"name\":\"Journal of Education, Health and Sport\",\"volume\":\"23 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Education, Health and Sport\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12775/jehs.2024.73.51729\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Education, Health and Sport","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12775/jehs.2024.73.51729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
简介和目的:遗传性秃发(AGA)是全球最常见的秃发原因之一。到 70 岁时,多达 80% 的男性和多达 40% 的绝经后女性会受到影响。在 AGA 的病因和发病机制中,遗传、患者年龄和雄激素的荷尔蒙效应这三个基本要素起着关键作用。在下面的综述中,我们介绍了美国食品及药物管理局(FDA)批准的和标示外的 AGA 治疗方法,以及这些方法的疗效和潜在副作用,患者应始终考虑到这些副作用,以防止中断治疗。AGA 的发病机制基于遗传性头皮皮肤对二氢睾酮(DHT)的敏感性,从而导致进行性脱发。文献记载了几种具有不同作用机制的治疗方法对 AGA 治疗的有效性,但迄今为止,只有外用米诺地尔和口服非那雄胺获得了美国食品及药物管理局的批准。米诺西地的作用机制是扩张血管,增加富含氧和生长因子的血液流向皮肤毛囊。5-α还原酶抑制剂,如非那雄胺(finasteride)和度他雄胺(dutasteride)是另一种三效合一的选择。它们通过抑制 5-α 还原酶(将睾酮转化为 DHT 的酶)发挥作用,而 DHT 是雄激素性脱发的主要致病因子。最近,米诺地尔和非那雄胺的局部应用,以及治疗雄激素性脱发的全新疗法越来越受到医生和患者的青睐。综述本综述介绍了目前治疗雄激素性脱发的方法,并考虑了这些方法的疗效、最佳剂量以及最常见的副作用。需要强调的一个重要事实是,雄激素性脱发是一种遗传倾向,治疗需要长期使用。因此,在选择药物时,必须与患者合作,结合不同的治疗方法,以达到理想的治疗效果,同时避免不良反应。
How to treat androgenetic alopecia – the most common form of hair loss. A review
Introduction and purposeAndrogenetic alopecia (AGA) is one of the most common causes of baldness worldwide. It affects up to 80% of men by the age of 70 and up to 40% of postmenopausal women. In AGA etiology and pathogenesis, the three essential components play a key role - genetic inheritance, patient age and hormonal effects of androgens. In the following review, we have described the available FDA-approved and off-label treatments for AGA, along with their efficacy and potential side effects that should always be considered to prevent treatment discontinuation by the patients.The state of knowledgeThe pathogenesis of AGA is based on inherited dihydrotestosterone (DHT) sensitivity in the scalp skin, which leads to progressive hair loss. The literature documents the effectiveness of several treatments with different mechanisms of action in AGA therapy, but only topical minoxidil and oral finasteride gained FDA approval so far. Minoxidil acts by the blood vessels dilatation that increases the flow of oxygenated and growth factor-enriched blood to the hair follicles in the skin. 5-alpha reductase inhibitors, such as finasteride and dutasteride are another threapeutic option. Thy act by the inhibition of 5-alpha reductase, the enzyme which converts testosterone to DHT - the main causative agent of androgenetic alopecia. Recently, topical applications of minoxidil and finasterid, along with completely new emerging treatments for androgenetic alopecia are gaining popularity among doctors and patients. SummaryThis review describes current treatments for AGA, considering their efficacy, optimal doses, and the most common side effects. An important fact to emphasise is that androgenetic alopecia is based on a genetic predisposition, and treatment requires long-term use. For this reason, when choosing a medication, it is essential to cooperate with the patient and combine different therapeutic methods to achieve the desirable outcome while avoiding adverse reactions.